BioELife Corp. (LITH)

BioELife Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Sep 30, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014
Net Income	-0.59	-0.34	-0.25	-0.21	-0.08	-0.5
Depreciation & Amortization	0	-	-	-	-	-
Other Amortization	0	0.05	0.1	0.09	0.03	0.01
Loss (Gain) From Sale of Assets	-	-0.68	-	-	-	-
Loss (Gain) From Sale of Investments	0.48	0.82	-	-	-	-
Stock-Based Compensation	-	-	-	-	-	0.01
Other Operating Activities	0.01	0.04	-	-	-0.02	0.4
Change in Accounts Payable	0.01	0.03	0.03	0.02	0.02	0.02
Change in Other Net Operating Assets	-0.03	-0	-0	-0.03	0.02	0.02
Operating Cash Flow	-0.12	-0.08	-0.12	-0.13	-0.03	-0.04
Capital Expenditures	-0.01	-0	-	-0	-	-
Sale of Property, Plant & Equipment	-	0.06	-	-	-	-
Investment in Securities	0.12	0	-	-	-	-
Investing Cash Flow	0.11	0.06	-	-0	-	-
Short-Term Debt Issued	-	0.02	0.12	0.14	0.03	-
Long-Term Debt Issued	-	-	-	-	0.01	0.03
Total Debt Issued	-	0.02	0.12	0.14	0.03	0.03
Net Debt Issued (Repaid)	-	0.02	0.12	0.14	0.03	0.03
Financing Cash Flow	-	0.02	0.12	0.14	0.03	0.03
Net Cash Flow	-0.01	0	-0.01	0.01	0	-0
Free Cash Flow	-0.13	-0.08	-0.12	-0.13	-0.03	-0.04
Free Cash Flow Per Share	-0.04	-0.03	-0.05	-0.06	-0.02	-0.03
Levered Free Cash Flow	-0.21	-0.03	-0.03	-0.06	-0.01	-0.25
Unlevered Free Cash Flow	-0.2	-0.03	-0.05	-0.08	-0.01	-0.24
Change in Net Working Capital	0.13	-0.02	-0.03	0.01	-0.03	-0.04

Source: S&P Capital IQ. Standard template. Financial Sources.